DUBLIN, Ireland, April 17, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/5lzjtt/diagnostic) has announced the addition of the "Diagnostic Imaging Market by X-ray Systems, Computed Tomography, Ultrasound Imaging Systems, MRI Machines, and Nuclear Imaging Systems - Global Forecasts to 2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
On the basis of type of modality, the global diagnostic market has been divided into five segments namely, X-ray imaging systems, computed tomography (CT) systems, ultrasound systems, magnetic resonance imaging (MRI) systems, and nuclear imaging systems. The X-ray imaging systems and ultrasound imaging systems segments are further sub-segmented into products based on the type of technology and portability. MRI systems are divided on the basis of type of architecture and field strength, whereas CT scanners are segmented by type of slice. The nuclear imaging systems are divided into Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) systems, which are further segmented into standalone systems and hybrid systems.
Some factors such as increasing investments and funds by government bodies worldwide, investments by public-private partnerships, increasing number of diagnostic procedures and diagnostic centers, rising number of cancer patients, and technological advancements are driving the global diagnostic imaging market. However, factors such as risk of radiation exposure, shortage of helium and technetium-99m, high cost of diagnostic systems, and technological limitations associated with standalone systems are restraining this market.
On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and RoW (Latin America, the Middle East, and Africa. In 2013, the global market was dominated by North America, followed by Europe. A number of factors such as increasing aging population, the high incidence/prevalence of various diseases (such as cancer and CVD), the large number of diagnostic imaging centers/procedures in this region, the large number of ongoing research activities, and faster adoption of technologically advanced imaging systems are driving the North American diagnostic imaging market. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2013 to 2018 due to factors such as increasing government initiatives for modernization of healthcare infrastructure, improvements in healthcare insurance coverage, and the growing number of ongoing research activities.
New product launches and product developments are the key strategies adopted by major players to strengthen their positions in the global market. Moreover, strategies such as expansions, partnerships, agreements, collaborations, and acquisitions were adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence.
Carestream Health (U.S.), Esaote S.p.A (Italy), GE Healthcare (U.K.), Hitachi Medical Corporation (Japan), Hologic, Inc. (U.S.), Philips Healthcare (Netherlands), Samsung Medison (South Korea), Shimadzu Corporation (Japan), Siemens Healthcare (Germany), and Toshiba Medical Systems Corporation (Japan) are the key players operating in the global market.
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Diagnostic Imaging Market, By Product
6 Geographic Analysis
7 Competitive Landscape
8 Company Profiles
- Carestream Health, Inc.
- Esaote S.P.A
- GE Healthcare
- Hitachi Medical Corporation
- Hologic, Inc.
- Philips Healthcare
- Samsung Medison
- Shimadzu Corporation
- Siemens Healthcare
- Toshiba Medical Systems Corporation
For more information visit http://www.researchandmarkets.com/research/5lzjtt/diagnostic
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets